UBS AM’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-50,564
| Closed | -$1.37M | – | 2877 |
|
|
2024
Q2 | $1.37M | Buy |
+50,564
| New | +$1.05M | ﹤0.01% | 2202 |
|
|
2023
Q4 | – | Sell |
-41,195
| Closed | -$618K | – | 2613 |
|
|
2023
Q3 | $618K | Sell |
41,195
-245,029
| -86% | -$5.1M | ﹤0.01% | 2202 |
|
|
2023
Q2 | $11.2M | Hold |
286,224
| – | – | 0.01% | 930 |
|
|
2023
Q1 | $11.2M | Sell |
286,224
-9,025
| -3% | -$441K | 0.01% | 930 |
|
|
2022
Q4 | $15.6M | Buy |
295,249
+21,577
| +8% | +$1.05M | 0.01% | 811 |
|
|
2022
Q3 | $12.3M | Sell |
273,672
-33,916
| -11% | -$1.46M | 0.01% | 891 |
|
|
2022
Q2 | $11.2M | Sell |
307,588
-2,002
| -0.6% | -$72.7K | 0.01% | 920 |
|
|
2022
Q1 | $12.8M | Buy |
309,590
+26,459
| +9% | +$931K | 0.01% | 975 |
|
|
2021
Q4 | $12.1M | Sell |
283,131
-2,160
| -0.8% | -$108K | ﹤0.01% | 1058 |
|
|
2021
Q3 | $15.7M | Sell |
285,291
-4,441
| -2% | -$232K | 0.01% | 934 |
|
|
2021
Q2 | $13.9M | Sell |
289,732
-13,957
| -5% | -$711K | 0.01% | 994 |
|
|
2021
Q1 | $15.4M | Sell |
303,689
-2,311
| -0.8% | -$128K | 0.01% | 942 |
|
|
2020
Q4 | $19.3M | Sell |
306,000
-8,963
| -3% | -$556K | 0.01% | 856 |
|
|
2020
Q3 | $21.2M | Buy |
314,963
+293,163
| +1,345% | +$16M | 0.01% | 747 |
|
|
2020
Q2 | $913K | Buy |
21,800
+15,300
| +235% | +$587K | ﹤0.01% | 1847 |
|
|
2020
Q1 | $205K | Buy |
6,500
+600
| +10% | +$24K | ﹤0.01% | 2272 |
|
|
2019
Q4 | $238K | Buy |
+5,900
| New | +$207K | ﹤0.01% | 2429 |
|
Other funds holding SILK
UBS AM's SILK Position: Q3 2024 in Review
UBS AM sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2024, closing a stake of 50,564 shares — an estimated $1.37M sold.
UBS AM first reported a position in SILK in Q4 2019 and held it in 17 quarters. The position peaked at $21.2M in Q3 2020. 1 fund tracked by Wall St. Rank holds SILK as of Q3 2024.
- UBS AM reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
- UBS AM sold 50,564 Silk Road Medical, Inc. Common Stock shares in Q3 2024, an estimated $1.37M.
- UBS AM first reported a position in Silk Road Medical, Inc. Common Stock in Q4 2019 and held it in 17 quarters.
- UBS AM's Silk Road Medical, Inc. Common Stock position peaked at $21.2M in Q3 2020.
- 1 fund tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2024.
Based on UBS AM's 13F filing for Q3 2024, filed 14 Nov 2024.